Q4 2022 Holdings
Filed 2023-02-13 | 16 holdings | $296.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Imago Biosciences | Common Stock | 45250K107 | $108.5M | 3,018,737 | 36.6% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $91.4M | 3,361,806 | 30.8% |
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $28.9M | 15,072,340 | 9.8% |
| Morphic Holding | Common Stock | 61775R105 | $16.0M | 597,723 | 5.4% |
| Alpine Immune Sciences(NVLSEUR) | Common Stock | 02083G100 | $14.9M | 2,029,580 | 5.0% |
| Cincor | Common Stock | 17240Y109 | $7.9M | 560,985 | 2.6% |
| Kronos Bio(KRON1USD) | Common Stock | 50107A104 | $6.2M | 3,818,283 | 2.1% |
| Ikena Oncology | Common Stock | 45175G108 | $6.0M | 2,249,123 | 2.0% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $3.7M | 1,971,241 | 1.2% |
| Theseus Pharmaceuticals | Common Stock | 88369M101 | $3.5M | 711,479 | 1.2% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $3.3M | 843,750 | 1.1% |
| Immunic Inc(IMUX) | Common Stock | 4525EP101 | $2.5M | 1,788,160 | 0.8% |
| Spruce Biosciences | Common Stock | 85209E109 | $2.3M | 2,161,022 | 0.8% |
| Syros Pharmaceuticals(SYRS) | Common Stock | 87184Q206 | $902.1K | 251,270 | 0.3% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $305.8K | 275,513 | 0.1% |
| Senti Biosciences, Inc. | Common Stock | 81726A100 | $276.1K | 195,792 | 0.1% |